Results 201 to 210 of about 323,198 (362)

Should Hospital Pharmacists Prescribe?

, 2014
Holly Mansell, Yvonne Hopf
openalex   +2 more sources

In vitro properties of patient serum predict clinical outcome after high dose rate brachytherapy of hepatocellular carcinoma

Molecular Oncology, EarlyView.
Following high dose rate brachytherapy (HDR‐BT) for hepatocellular carcinoma (HCC), patients were classified as responders and nonresponders. Post‐therapy serum induced increased BrdU incorporation and Cyclin E expression of Huh7 and HepG2 cells in nonresponders, but decreased levels in responders.
Lukas Salvermoser, Jan Niklas Schäfer, Shraga Nahum Goldberg, Philipp Maximilian Kazmierczak, Moritz Nikolaus Gröper, Philipp Franz Linden, Elif Öcal, Tanja Burkard, Stefanie Corradini, Najib Ben Khaled, Moritz Wildgruber, Max Seidensticker, Jens Ricke, Matthias Stechele, Marianna Alunni‐Fabbroni   +14 more
wiley   +1 more source

Confronting antimicrobial resistance in Jordan: regulatory, economic, and behavioral determinants of non-prescription antibiotic dispensing in community pharmacies-a mixed-methods study. [PDF]

Front Med (Lausanne)
Abed A, Abu Assab M, Merdas ZJH, Abu Dayyih W, Maaita MN, Zakaraya Z, Alotaibi BS, Alsubaie N.   +7 more
europepmc   +1 more source

Adoption of telepharmacy among pharmacists, physicians, and nurses at Hawassa City Public Hospitals, Ethiopia

Jenberu Mekurianew Kelkay, Henok Dessie Wubneh, Henok Molla Beri, Abel Melaku Tefera, Rediet Abebe Molla, Addisu Alem Negatu   +5 more
openalex   +2 more sources

Community pharmacists are increasingly supervising treatments

, 1996
Rodney J. Scott, Helene McNulty
openalex   +2 more sources

Inhibition of CDK9 enhances AML cell death induced by combined venetoclax and azacitidine

Molecular Oncology, EarlyView.
The CDK9 inhibitor AZD4573 downregulates c‐MYC and MCL‐1 to induce death of cytarabine (AraC)‐resistant AML cells. This enhances VEN + AZA‐induced cell death significantly more than any combination of two of the three drugs in AraC‐resistant AML cells.
Shuangshuang Wu, Jianlei Zhao, Aaban Asfar Azmi, Avanti Gupte, Jenna Thibodeau, Shuang Liu, Jinli Yang, Guan Wang, Holly Edwards, Lisa A. Polin, Juiwanna Kushner, Sijana H. Dzinic, Kathryn White, Julie Boerner, Maik Hüttemann, Jay Yang, Yue Wang, Jeffrey W. Taub, Yubin Ge   +18 more
wiley   +1 more source

Development of well-being assessment criteria for pharmacists: a mixed-methods study in the Eastern Special Development Zone of Thailand. [PDF]

J Pharm Policy Pract
Luengalongkot P, Makmee P, Daorueng C.
europepmc   +1 more source

Pharmacist educators: empowering pharmacists for medical education

European Journal of Hospital Pharmacy
Shih-Chieh Shao, Kai-Cheng Chang, Shu-Chen Liao, Yu-Che Chang, Rong-Nan Chien   +4 more
openaire   +3 more sources

Pharmacists\u27 Right of Conscience: Strategies for Showing Respect for Pharmacists\u27 Beliefs While Maintaining Adequate Care for Patients [PDF]

, 2006
Yoder, Jessica D.
core   +1 more source

A synthetic benzoxazine dimer derivative targets c‐Myc to inhibit colorectal cancer progression

Molecular Oncology, EarlyView.
Benzoxazine dimer derivatives bind to the bHLH‐LZ region of c‐Myc, disrupting c‐Myc/MAX complexes, which are evaluated from SAR analysis. This increases ubiquitination and reduces cellular c‐Myc. Impairing DNA repair mechanisms is shown through proteomic analysis.
Nicharat Sriratanasak, Bodee Nutho, Worawat Wattanathana, Narumon Phaonakrop, Bunnatut Panasawatwong, Katharina Erlenbach‐Wuensch, Sittiruk Roytrakul, Regine Schneider‐Stock, Pithi Chanvorachote   +8 more
wiley   +1 more source